China Life Insurance Co Ltd

China Life’s 2026 meeting shows modest premium growth, but hidden declines in ROE and asset‑liability ratios raise risk‑management concerns for investors and policyholders.

China Life’s 12.5 billion‑yuan AI and pension fund push and 9 billion‑yuan hotel deal show how insurers are diversifying into tech and real‑estate, boosting returns and easing underwriting pressures.

China Life Insurance celebrates 30 years while launching AI‑focused private‑equity and pension‑sector funds, aiming for 4.8% premium growth and high‑IRR returns.

China Life’s HK$500 million AI‑tech fund launch shows how insurers are shifting capital toward high‑growth, tech‑led sectors to offset cyber‑risk costs and drive long‑term value.

China Life Insurance shares dip to a 52‑week low, yet its low P/E and strong capital base keep it attractive for value investors amid sector softness.

China Life Insurance’s unanimous 2025 consumer‑rights audit approval raises questions about internal bias and limited transparency, prompting calls for external scrutiny.

China Life Insurance’s HK share rise on 17 Dec 2025 highlights a broader financial‑sector rebound driven by strong macro data, easing rates and clearer regulation—insights on capital strategy, digital growth, ESG and cross‑border expansion for insti…

China Life Insurance’s December rally shows how lower capital rules and regional projects are boosting the life‑insurance sector, giving investors a clear case for long‑term exposure.

China Life Insurance hits a record RMB 700 billion premiums, boosting its market share and investor confidence while driving growth in China’s life‑insurance sector.

China Life Insurance’s 700 billion‑yuan premium surge shows how long‑dated, fixed‑term products and Henan‑focused asset growth can boost margins, but also raise longevity and regional risks—insightful analysis for investors.